Evergraf 0.25mg Tablet: Effective Medication for Your Needs

Uses:

• Advanced breast cancer;
• Advanced renal cell carcinoma;
• Advanced pancreatic neuroendocrine tumours;
• Treatment of subependymal giant cell astrocytoma.

How it works:

• Evergraf 0.25mg tablet inhibits the activity of a protein called mammalian target of rapamycin (mTOR), which regulates cell growth.
• This drug can slow the growth of abnormal cancer cells by blocking the mTOR protein and helps to reduce the size of tumours and improve outcomes in patients.

Important information:

• Store Evergraf 0.25mg tablet in the original package at room temperature (20°C to 25°C).
• Keep it out of reach from children.
• Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, nutritional or vitamin supplements, and herbal products.
• Do not crush, chew, or open the medicine.
• Only stop taking the tablet if your doctor advises you to stop.

Safety advice:

• Pregnancy: Evergraf 0.25mg tablet is not recommended for pregnant women as it may cause fetal harm. Consult your doctor if you are pregnant or planning for pregnancy during the treatment.
• Breastfeeding: Evergraf 0.25mg tablet passes into your breast milk and harms your baby. It is unsafe to consume this tablet.
• Lungs: It is not known whether Evergraf 0.25mg tablet can be used for patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.
• Liver: Inform your doctor if you have any liver problems before taking Evergraf 0.25mg tablet. Regular monitoring of liver function tests is recommended.
• Alcohol: Consuming alcohol may affect the effectiveness of Evergraf 0.25mg tablet. Stop consuming alcohol if you are taking this medicine.
• Driving: It is unsafe to drive vehicles or operate heavy machinery after taking Evergraf 0.25mg tablet, it may cause dizziness and impair your concentration.

Side effects:

• Serious: difficulty breathing or swallowing, swelling of face, lips, tongue, throat, severe itching, red rash, raised bumps.
• Common: infection (chills, increased temperature), coughing, wheezing, excessive thirst, high urine output or severely decreased urine output, tiredness, bleeding, increased appetite with weight loss.

FAQ:

1. What you should know before taking Evergraf 0.25mg tablet? Before taking Evergraf 0.25mg tablet, it is important to know that your risk of getting bacterial or viral infection increases with this treatment. If you have been infected with Hepatitis B, this drug increases the chances of reinfection. Tell your healthcare provider if you experience fever, chills, cough, yellowing of the skin, joint pain, or swelling during this treatment.
2. Is it safe to use Evergraf 0.25mg tablet during pregnancy? Evergraf 0.25mg tablets have the tendency to cause harm to the unborn fetus. Inform your healthcare provider before starting this treatment if you are pregnant, or planning for pregnancy. Your healthcare provider will conduct a pregnancy test before you start treatment with this drug.
3. What are the side effects of Evergraf 0.25mg Tablet? The common side effects that are likely to occur while you are on the treatment with Evergraf 0.25mg tablet are fever, chills, skin rash, joint pain, swelling, tiredness, loss of appetite, high risk of infection, mouth ulcers, and difficulty breathing.
4. Is it safe to undergo surgery while on treatment with Evergraf 0.25mg tablet? Evergraf 0.25mg tablet may lead to poor wound healing ability. Consult your healthcare provider and stop taking this tablet at least one week before planned surgery.
5. Can I drink alcohol while taking Evergraf 0.25mg tablet? It is generally recommended to avoid drinking alcohol while taking Evergraf 0.25mg tablet, as alcohol can increase the risk of liver damage.

Fact box:

• Molecule name: Everolimus;
• Therapeutic class: Antineoplastics;
• Pharmacological class: mTOR kinase inhibitors.

Tags: Evergraf, Tablet, 0.25mg, Medical, Health, Drug, Medicine